Approval · Notice of Compliance 36356 · 2025
ZENRELIA: Notice of Compliance 36356
Issued November 12, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36356
- Date
- November 12, 2025
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update
Products in this notice
Medicinal ingredients
- ILUNOCITINIB 4.8 MG per TAB
- ILUNOCITINIB 6.4 MG per TAB
- ILUNOCITINIB 8.5 MG per TAB
- ILUNOCITINIB 15 MG per TAB